Article
Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.
Clinical pharmacology and therapeutics - 1 Sept 1998
Kashuba A D, Nafziger A N, Kearns G L, Leeder J S, Gotschall R, Rocci M L, Kulawy R W, Beck D J, Bertino J S
Abstract excerpt
OBJECTIVE: To determine the effect of 150 mg/day fluvoxamine on the activities of CYP1A2, CYP2D6, CYP3A, N-acetyltransferase-2 (NAT2), and xanthine oxidase (XO) by phenotyping with caffeine, dextromethorphan, and midazolam. METHODS: Oral caffeine (2 mg/kg), oral dextromethorphan (30 mg), and intr...
Topics
- Acetyltransferases
- Adult
- Anti-Anxiety Agents
- Antitussive Agents
- Aryl Hydrocarbon Hydroxylases
- Caffeine
- Central Nervous System Stimulants
- Cytochrome P-450 CYP1A2 Inhibitors
- Cytochrome P-450 CYP2D6 Inhibitors
- Cytochrome P-450 CYP3A
- Cytochrome P-450 Enzyme Inhibitors
- Dextromethorphan
- Female
